INTELLIGENT BIO SOLUTIONS INC. Earnings Per Share (Basic)
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Earnings Per Share (Basic) of -$8.44 per share for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. earnings per share, basic for the quarter ending 2026-06-30 was -$1.56.
- INTELLIGENT BIO SOLUTIONS INC. earnings per share, basic for the quarter ending 2026-03-31 was -$1.80.
- INTELLIGENT BIO SOLUTIONS INC. earnings per share, basic for the quarter ending 2025-12-31 was -$2.82.
- INTELLIGENT BIO SOLUTIONS INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.35.
- INTELLIGENT BIO SOLUTIONS INC. earnings per share, basic for fiscal 2026 was -$8.44.
- INTELLIGENT BIO SOLUTIONS INC. earnings per share, basic for fiscal 2025 was -$20.04.
- INTELLIGENT BIO SOLUTIONS INC. earnings per share, basic for fiscal 2024 was -$6.38.
- INTELLIGENT BIO SOLUTIONS INC. earnings per share, basic for fiscal 2023 was -$127.00.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.56 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$3.31 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$5.62 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$8.44 10-K · filed 2026-08-19 | ||||
| 2026-03-31 | -$1.80 10-Q · filed 2026-05-13 | -$4.35 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$7.54 10-Q · filed 2026-05-13 | -$3.94 derived: net income ÷ weighted average shares · filed 2026-08-19 | ||||
| 2025-12-31 | -$2.82 10-Q · filed 2026-02-12 | -$6.27 10-Q · filed 2026-02-12 | -$2.57 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$4.19 derived: net income ÷ weighted average shares · filed 2026-08-19 | ||||
| 2025-09-30 | -$0.35 10-Q · filed 2025-11-12 | -$1.31 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$2.63 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$4.23 derived: net income ÷ weighted average shares · filed 2026-08-19 | ||||
| 2025-06-30 | -$4.42 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$8.82 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$13.66 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$20.04 10-K · filed 2026-08-19 | -$2.00 10-K · filed 2025-08-15 | |||
| 2025-03-31 | -$4.41 10-Q · filed 2026-05-13 | -$0.44 10-Q · filed 2025-05-13 | -$9.30 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$15.92 10-Q · filed 2026-05-13 | -$1.59 10-Q · filed 2025-05-13 | -$5.21 derived: net income ÷ weighted average shares · filed 2026-05-13 | ||
| 2024-12-31 | -$4.96 10-Q · filed 2026-02-12 | -$0.50 10-Q · filed 2025-02-13 | -$11.82 10-Q · filed 2026-02-12 | -$1.18 10-Q · filed 2025-02-13 | -$3.17 derived: net income ÷ weighted average shares · filed 2026-02-12 | -$4.56 derived: net income ÷ weighted average shares · filed 2026-02-12 | ||
| 2024-09-30 | -$0.70 10-Q · filed 2025-11-12 | -$1.60 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$2.84 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$4.22 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||||
| 2024-06-30 | -$0.92 derived: net income ÷ weighted average shares · filed 2025-08-15 | -$2.25 derived: net income ÷ weighted average shares · filed 2025-08-15 | -$3.82 derived: net income ÷ weighted average shares · filed 2025-08-15 | -$6.38 10-K · filed 2025-08-15 | ||||
| 2024-03-31 | -$1.43 10-Q · filed 2025-05-13 | -$3.27 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$6.64 10-Q · filed 2025-05-13 | -$12.05 derived: net income ÷ weighted average shares · filed 2025-05-13 | ||||
| 2023-12-31 | -$2.07 10-Q · filed 2025-02-13 | -$7.68 10-Q · filed 2025-02-13 | -$16.94 derived: net income ÷ weighted average shares · filed 2025-02-13 | -$39.96 derived: net income ÷ weighted average shares · filed 2025-02-13 | ||||
| 2023-09-30 | -$12.48 10-Q · filed 2024-11-07 | -$1.04 10-Q · filed 2023-11-08 | -$33.99 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$87.56 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$101.43 derived: net income ÷ weighted average shares · filed 2024-11-07 | |||
| 2023-06-30 | -$25.33 derived: net income ÷ weighted average shares · filed 2024-09-18 | -$91.23 derived: net income ÷ weighted average shares · filed 2024-09-18 | -$103.53 derived: net income ÷ weighted average shares · filed 2024-09-18 | -$127.00 10-K · filed 2024-09-18 | -$10.58 10-K · filed 2023-08-23 | |||
| 2023-03-31 | -$68.67 10-Q · filed 2024-05-08 | -$5.72 10-Q · filed 2023-05-11 | -$80.49 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$104.04 10-Q · filed 2024-05-08 | -$8.67 10-Q · filed 2023-05-11 | -$2.54 derived: net income ÷ weighted average shares · filed 2024-05-08 | ||
| 2022-12-31 | -$5.56 10-Q · filed 2024-02-09 | -$0.46 10-Q · filed 2023-02-14 | -$23.65 10-Q · filed 2024-02-09 | -$1.97 10-Q · filed 2023-02-14 | -$0.71 derived: net income ÷ weighted average shares · filed 2024-02-09 | -$1.23 derived: net income ÷ weighted average shares · filed 2024-02-09 | ||
| 2022-09-30 | -$1.62 10-Q · filed 2023-11-08 | -$0.08 10-Q · filed 2022-11-14 | -$0.42 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.85 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$1.89 derived: net income ÷ weighted average shares · filed 2023-11-08 | |||
| 2022-06-30 | -$2.79 derived: net income ÷ weighted average shares · filed 2023-08-23 | -$4.58 derived: net income ÷ weighted average shares · filed 2023-08-23 | -$9.23 derived: net income ÷ weighted average shares · filed 2023-08-23 | -$11.33 10-K · filed 2023-08-23 | -$0.57 10-K · filed 2022-09-22 | |||
| 2022-03-31 | -$1.79 10-Q · filed 2023-05-11 | -$0.09 10-Q · filed 2022-05-16 | -$6.44 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$8.54 10-Q · filed 2023-05-11 | -$0.43 10-Q · filed 2022-05-16 | -$1.01 derived: net income ÷ weighted average shares · filed 2023-05-11 | ||
| 2021-12-31 | -$4.65 10-Q · filed 2023-02-14 | -$6.77 10-Q · filed 2023-02-14 | -$0.63 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$0.91 derived: net income ÷ weighted average shares · filed 2023-02-14 | ||||
| 2021-09-30 | -$0.10 10-Q · filed 2022-11-14 | -$0.17 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.42 derived: net income ÷ weighted average shares · filed 2022-11-14 | |||||
| 2021-06-30 | -$0.07 derived: net income ÷ weighted average shares · filed 2022-09-22 | -$0.33 derived: net income ÷ weighted average shares · filed 2022-09-22 | -$0.68 10-K · filed 2022-09-22 | |||||
| 2021-03-31 | -$0.27 10-Q · filed 2022-05-16 | -$0.64 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |